AtriCure Revenue 2006-2019 | ATRC

AtriCure revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
AtriCure Annual Revenue
(Millions of US $)
2019 $231
2018 $202
2017 $175
2016 $155
2015 $130
2014 $107
2013 $82
2012 $70
2011 $64
2010 $59
2009 $55
2008 $55
2007 $48
2006 $38
2005 $31
AtriCure Quarterly Revenue
(Millions of US $)
2019-12-31 $61
2019-09-30 $57
2019-06-30 $59
2019-03-31 $54
2018-12-31 $53
2018-09-30 $50
2018-06-30 $52
2018-03-31 $47
2017-12-31 $46
2017-09-30 $42
2017-06-30 $45
2017-03-31 $41
2016-12-31 $41
2016-09-30 $38
2016-06-30 $40
2016-03-31 $36
2015-12-31 $36
2015-09-30 $31
2015-06-30 $33
2015-03-31 $30
2014-12-31 $29
2014-09-30 $27
2014-06-30 $27
2014-03-31 $25
2013-12-31 $22
2013-09-30 $20
2013-06-30 $20
2013-03-31 $19
2012-12-31 $18
2012-09-30 $16
2012-06-30 $18
2012-03-31 $17
2011-12-31 $17
2011-09-30 $15
2011-06-30 $17
2011-03-31 $16
2010-12-31 $16
2010-09-30 $14
2010-06-30 $14
2010-03-31 $14
2009-12-31 $14
2009-09-30 $13
2009-06-30 $14
2009-03-31 $14
2008-12-31 $12
2008-09-30 $15
2008-06-30 $15
2008-03-31 $14
2007-12-31 $13
2007-09-30 $12
2007-06-30 $12
2007-03-31 $11
2006-12-31 $11
2006-09-30 $9
2006-06-30 $10
2006-03-31 $9
2005-12-31 $9
2005-09-30 $7
2005-06-30 $8
2005-03-31 $7
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.310B $0.231B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $139.911B 24.49
Medtronic (MDT) Ireland $123.362B 16.59
Stryker (SYK) United States $61.082B 19.73
Boston Scientific (BSX) United States $44.176B 19.90
Baxter (BAX) United States $41.692B 25.45
Coloplast (CLPBY) Denmark $30.866B 47.63
Lonza Group Ag (LZAGY) Switzerland $30.841B 0.00
Terumo (TRUMY) Japan $26.173B 32.66
EssilorLuxottica Societe Anonyme (ESLOY) France $23.905B 0.00
ResMed (RMD) United States $22.301B 38.75
Zimmer Biomet Holdings (ZBH) United States $20.285B 12.49
Smith & Nephew SNATS (SNN) United Kingdom $15.852B 0.00
Sunny Optical Technology (SNPTF) China $15.257B 0.00
Insulet (PODD) United States $10.975B 671.46
Bio-Rad Laboratories (BIO) United States $10.447B 48.83
William Demant Holdings (WILYY) Denmark $7.898B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Hill-Rom Holdings (HRC) United States $6.805B 19.57
Perrigo (PRGO) Ireland $6.644B 12.11
GN STORE NORD (GNNDY) Denmark $5.673B 29.31
Haemonetics (HAE) United States $5.127B 31.56
Canopy Growth (CGC) Canada $5.052B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Quidel (QDEL) United States $4.340B 38.10
ICU Medical (ICUI) United States $4.090B 26.71
Neogen (NEOG) United States $3.507B 59.41
GW Pharmaceuticals (GWPH) United Kingdom $2.634B 0.00
NuVasive (NUVA) United States $2.600B 20.10
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.450B 0.00
Agios Pharmaceuticals (AGIO) United States $2.425B 0.00
Envista Holdings (NVST) United States $2.397B 0.00
National Vision Holdings (EYE) United States $1.570B 26.46
Cardiovascular Systems (CSII) United States $1.252B 0.00
TG Therapeutics (TGTX) United States $1.129B 0.00
Aurora Cannabis (ACB) Canada $1.080B 0.00
Phibro Animal Health (PAHC) United States $0.916B 18.11
NanoString Technologies (NSTG) United States $0.886B 0.00
Aphria (APHA) $0.823B 0.00
VAREX IMAGING (VREX) United States $0.807B 16.78
Cerus (CERS) United States $0.757B 0.00
InMode (INMD) Israel $0.673B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.672B 120.92
PetIQ (PETQ) United States $0.658B 17.91
Eagle Pharmaceuticals (EGRX) United States $0.620B 36.84
Omeros (OMER) United States $0.618B 0.00
OraSure Technologies (OSUR) United States $0.609B 75.61
Quanterix (QTRX) United States $0.532B 0.00
Owens & Minor (OMI) United States $0.529B 14.47
LeMaitre Vascular (LMAT) United States $0.495B 27.88
Lantheus Holdings (LNTH) United States $0.488B 10.97
Surmodics (SRDX) United States $0.424B 48.70
Vapotherm (VAPO) United States $0.420B 0.00
Zynex (ZYXI) United States $0.354B 38.57
Organigram Holdings (OGI) Canada $0.351B 0.00
Meridian Bioscience (VIVO) United States $0.341B 13.74
Utah Medical Products (UTMD) United States $0.331B 23.67
MacroGenics (MGNX) United States $0.289B 0.00
Repro-Med Systems (KRMD) United States $0.285B 179.50
Cytosorbents (CTSO) United States $0.230B 0.00
HEXO (HEXO) $0.224B 0.00
Female Health (VERU) United States $0.213B 0.00
BioLife Solutions (BLFS) United States $0.201B 123.13
Exagen (XGN) United States $0.182B 0.00
Viemed Healthcare (VMD) United States $0.176B 19.87
InfuSystems Holdings (INFU) United States $0.168B 141.33
United Health Products (UEEC) United States $0.155B 0.00
Rockwell Medical (RMTI) United States $0.138B 0.00
Evolus (EOLS) United States $0.136B 0.00
Bovie Medical (APYX) United States $0.122B 0.00
Liberty Health Sciences (LHSIF) Canada $0.115B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.109B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.091B 0.00
Fonar (FONR) United States $0.091B 6.63
Brainsway (BWAY) Israel $0.076B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.068B 0.00
United-Guardian (UG) United States $0.065B 13.65
MTech Acquisition (KERN) United States $0.065B 0.00
Wound Management Technologies (SMTI) United States $0.061B 0.00
Nephros (NEPH) United States $0.055B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
Surface Oncology (SURF) United States $0.053B 0.00
GUARDION HEALTH (GHSI) United States $0.031B 0.00
ImmuCell (ICCC) United States $0.029B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00